Is angiotensin-II an endogenous pro-inflammatory molecule?

Area of Science:

• Biochemistry
• Immunology
• Cardiovascular Science

Background:

• Angiotensin-II, produced by angiotensin-converting enzyme (ACE), plays a key role in regulating vascular tone and inflammatory processes.
• ACE activity and elevated angiotensin-II levels are implicated in initiating and sustaining inflammation.
• ACE is found in numerous tissues, suggesting widespread roles for angiotensin-II.

Purpose of the Study:

• To explore the pro-inflammatory nature of angiotensin-II.
• To investigate the potential role of angiotensin-II in a range of inflammatory diseases.
• To evaluate the therapeutic implications of targeting the renin-angiotensin system for inflammatory conditions.

Main Methods:

• Review of existing literature on angiotensin-II's biochemical actions.
• Analysis of angiotensin-II's involvement in inflammatory pathways (cytokine release, NFkappaB activation, oxidant stress, nitric oxide suppression).
• Correlation of ACE tissue distribution with the pathophysiology of various diseases.

Main Results:

• Angiotensin-II exhibits pro-inflammatory properties by stimulating inflammatory mediators and increasing oxidant stress.
• Increased ACE activity and angiotensin-II concentrations are linked to the initiation and perpetuation of inflammation.
• The widespread presence of ACE suggests angiotensin-II's involvement in conditions like atherosclerosis, heart failure, neurological disorders, and various inflammatory diseases.

Conclusions:

• Angiotensin-II is inherently pro-inflammatory and contributes to the pathogenesis of numerous diseases.
• ACE inhibitors and angiotensin-II receptor blockers may be beneficial in managing inflammatory conditions beyond hypertension and congestive heart failure.
• Development of novel ACE inhibitors or angiotensin-II receptor blockers with enhanced anti-inflammatory properties is warranted.